IFP Advisors’s Mesoblast MESO Stock Holding History

IFP Advisors’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$132	Buy	+9	New	+$143	﹤0.01%	4942
2020 Q4	–	Sell	-500	Closed	-$12.3K	–	3034
2020 Q3	$19K	Buy	+500	New	+$15.7K	﹤0.01%	1675
2018 Q4	–	Sell	-500	Closed	-$8K	–	3734
2018 Q3	$8K	Sell	500 -506	-50%	-$6.42K	﹤0.01%	2980
2018 Q2	$11K	Buy	1,006 +506	+101%	+$5.78K	﹤0.01%	2836
2018 Q1	$6K	Hold	500	–	–	﹤0.01%	3083
2017 Q4	$6K	Hold	500	–	–	﹤0.01%	3129
2017 Q3	$5K	Hold	500	–	–	﹤0.01%	3404
2017 Q2	$8K	Hold	500	–	–	﹤0.01%	3165
2017 Q1	$9K	Hold	500	–	–	﹤0.01%	2986
2016 Q4	$5K	Hold	500	–	–	﹤0.01%	3305
2016 Q3	$4K	Buy	+500	New	+$4.66K	﹤0.01%	3341

Other funds holding MESO

Penbrook Management New York $169M AUM 32.52% 1-Year Est. Return

Lazari Capital Management Woodland Hills, California $339M AUM 25.58% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

IFP Advisors's MESO Position: Q3 2026 in Review

IFP Advisors opened a new position in Mesoblast (MESO) in Q3 2026: 9 shares worth $132. The stake represents ﹤0.01% of the portfolio and ranks #4942 among its holdings. This is a return to the name: IFP Advisors previously reported a position in MESO as recently as Q3 2020.

IFP Advisors first reported a position in MESO in Q3 2016 and has held it in 11 quarters since. The position peaked at $19K in Q3 2020. 6 funds tracked by Wall St. Rank hold MESO as of Q3 2026.

IFP Advisors held 9 shares of Mesoblast worth $132 as of Q3 2026.
Mesoblast was a new IFP Advisors position in Q3 2026.
Mesoblast made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4942 holding.
IFP Advisors first reported a position in Mesoblast in Q3 2016 and has held it in 11 quarters since.
IFP Advisors's Mesoblast position peaked at $19K in Q3 2020.
6 funds tracked by Wall St. Rank held Mesoblast as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.